Enhancing Early Diagnosis: Multimodal AI Approaches for Neurodegenerative Diseases
Journal of Biotechnology and Biomedicine · 2026 · 9 (1)
DOI: 10.26502/jbb.2642-91280211 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biotechnology and Biomedicine, 2026. Verfasst von Aneesh Swamy und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Research, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, California 91766…. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Neurodegenerative diseases such as Alzheimer's and Parkinson's impose a staggering global burden, yet timely identification remains hindered by a fundamental mismatch between the slow unfolding of pathology and the static nature of traditional diagnostic frameworks. While conventional clinical markers often fail to identify decline until irreversible neuronal loss has occurred, artificial intelligence (AI)-driven biomarkers derived from neuroimaging, electrophysiology, and digital phenotyping offer a transformative proactive paradigm. This review evaluates how machine-learning models extract high- dimensional, subvisual patterns from MRI, PET, and EEG datasets to detect preclinical deviations that outpace traditional markers in predictive timelines. We argue that the primary value of these technologies lies in a categorical shift toward continuous, temporally informed disease modeling designed to fill the "detection gap" between early protein accumulation and overt clinical impairment. By synthesizing evidence across various modalities, we highlight the superior performance of multimodal fusion architectures in capturing the biological complexity of neurodegeneration. However, clinical translation faces significant hurdles, including data heterogeneity, the "black-box" nature of deep learning, and the necessity for global equity in dataset representation. Ultimately, by integrating explainable AI with longitudinal data streams, these biomarkers can redefine neurodegenerative care-transforming diagnosis from a reactive confirmation of damage into a precise tool for risk stratification, trial enrichment, and early therapeutic intervention.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Translational Research, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, California 91766 USA.
Förderung
- NIAID NIH HHS
Zitieren
APA
Swamy, A., & Agrawal, D. K. (2026). Enhancing Early Diagnosis: Multimodal AI Approaches for Neurodegenerative Diseases. Journal of Biotechnology and Biomedicine, 9(1). https://doi.org/10.26502/jbb.2642-91280211
Vancouver
Swamy A, Agrawal DK. Enhancing Early Diagnosis: Multimodal AI Approaches for Neurodegenerative Diseases. Journal of Biotechnology and Biomedicine. 2026;9(1). doi:10.26502/jbb.2642-91280211
BibTeX
@article{Swamy2026,
author = {Swamy, Aneesh and Agrawal, Devendra K},
title = {Enhancing Early Diagnosis: Multimodal AI Approaches for Neurodegenerative Diseases},
journal = {Journal of Biotechnology and Biomedicine},
year = {2026},
volume = {9},
number = {1},
doi = {10.26502/jbb.2642-91280211}
}
EUVIMED